Effects of non-ionic surfactant on the release of protein drug from poly(DL-lactide-co-glycolide) microspheres

Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 4-6, 2008, Pages 798-803

  Kim, Hyung Soo ^a   Shin, Taek Hwan ^a   Yoon, Mikyeong ^a   Kang, Myung Joo ^a   Lee, Jaehwi ^a   Choi, Young Wook ^a  

^a Chung Ang University   (South Korea)

Author keywords

Diphtheria toxoid; Drug release; Non ionic surfactant; PLGA microspheres; Surface antigen

Indexed keywords

DIPHTHERIA TOXOID; DRUG RELEASE; HYDROPHOBIC INTERACTIONS; LOADING EFFICIENCY; MICROENCAPSULATION PROCESS; PLGA MICROSPHERES; POLY(DL-LACTIDE-COGLYCOLIDE); SURFACE ANTIGEN;

COPOLYMERS; EMULSIFICATION; MICROSPHERES; SURFACE ACTIVE AGENTS;

ANTIGENS;

EID: 84884551617     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. AA Ignatius, LE Claes, in vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide), Biomaterials, 17, 831 (1996)
2. YK Ko, SH Kim, HJ Ha, et al, Tissue engineered biodisc using human intervertebral disc cells and PLGA/DBP scaffolds, Tissue Eng Regen Med, 4, 67 (2007).
3. MS Shive, JM Anderson, Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv Drug Deliv Rev, 13, 5 (1997).
4. SK Kim, KD Hong, SH Kim, et al., Preparation of tissue engineered spinal cord using bone marrow stromal cells and porous scaffold, Tissue Eng Regen Med, 2, 130 (2005).
5. JH Lee, JY Lim, SI Ahn, et al., Fabrication and characterization of SIS/PLGA film impregnated with dexamethasone, Tissue Eng Regen Med, 5, 451 (2008).
6. P Johansen, Y Men, HP Merkle, et al., Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination, Eur J Pharm Biopharm, 50, 129 (2000).
7. JT Garcia, JB Farina, O Munguia, et al., Comparative degradation study of biodegradable microspheres of poly(DL-lactide-co-glycolide) with poly(ethylene glycol)derivatives, J Microencapsul, 16, 83 (1999).
8. JC Cho, G Khang, HB Lee, et al., Preparation of biodegradable PLGA microspheres for sustained local anesthesia and their in vitro release behavior, Polymer(Korea), 24, 728 (2000).
9. JW So, SH Kim, MO Baek, et al., Effect of size of PLGA microsphere on proliferation and phenotype for human intervertebral disc cells, Tissue Eng Regen Med, 4, 577 (2007).
10. EK Jeon, G Khang, I Lee, et al., Preparation and release profile of NGF-loaded polylactide scaffolds for tissue engineered nerve regeneration, Polymer(Korea), 25, 893 (2001).
11. HS Choi, G Khang, H Shin, et al., Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles, Int J Pharm, 234, 195 (2002).
12. D Gray, H Skarvall, B-cell memory is short lived in the absence of antigen, Nature, 70, 336 (1988).
13. AGA Coombes, EC Lavelle, PG Jenkins et al., Single dose polymeric microparticulate vaccine delivery systems: the influence of formulation conditions on the magniude and duration of the immune response to a protein antigen, Vaccine, 14, 1429 (1996).
14. M Kois, N Fukuhara, T Kondo, Studies on microcapules. I V. Preparation and some propertics of sulfonated polyphthalamide microcapsules, Can J Chem, 47, 3447 (1969).
15. R Miller, VB Fainerman, AV Makievski, et al., Dynamics of protein and mixed protein/surfactant adsorption layers at the water/fluid interface, Adv Colloid Interfac, 86, 39 (2000).
16. RC Mehta, R Jeyanthi, S Calis, et al., Biodegradable microspheres as depot system for parental delivery of peptide drugs, J Control Release, 29, 375 (1994).
17. PJ Watts, MC Davis, CD Melia, Microencapsulation using emulsification/solvent evaporation; an overview of techniques and applications, Crit Rev Ther Drug, 7, 235 (1990).
18. JP Benoit, H Marchais, H Rolland, et al., Biodegradable microspheres: advances in production technology, In Microencapsulation: Methods and Industrial Applications, Eds, Marcel Dekker, New York 1 (1996).
19. DT. O'Hagan, H Jeffery, SS Davis, The preparation and characterization of poly(lactide-co-glycolide) microspheres: III. Microparticle/polymer degradation rate and the in vitro release of a model protein, Int J Pharm, 103, 37 (1994).
20. 1 in a lipid emulsion by ultrafiltration, Pharm Res, 5, 482 (1988).
21. YY Yang, TS Chung, N N.g., Morphology, drug distribution and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method, Biomaterials, 22, 231 (2001).
22. JS Park, JH Lee, HS Shin, et al., Microemulsions as carriers for drugs and nutraceuticals, Tissue Eng Regen Med, 4(4), 502 (2007).
23. F Ito, H Fujimori, K Makino, Incorporation of water-soluble drugs in PLGA microspheres, Colloids Surfaces B, 54, 173 (2007).
24. BO Patrick, WM James, Preparation of microspheres by the solvent evaporation technique, Adv Drug Deli Rev, 28, 25 (1997).
25. JL Cleland, AJS Jones, Stable formulation of recombinant human growth hormone and interferone for microencapsulation in biodegradable microspheres, Pharm Res, 13, 1464 (1996).
26. S Cohen, T Yoshioka, M Lucarelli, et al., Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microsphere, Pharm Res, 8, 713 (1991).